Brief: vTv Therapeutics Board Approved A Reverse Stock Split At A Ratio Of 1-For-40
Nov 15 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS INC - ON NOVEMBER 14, BOARD APPROVED A
REVERSE
STOCK SPLIT AT A RATIO OF 1-FOR-40
* VTV THERAPEUTICS INC - REVERSE STOCK SPLIT WILL BE
EFFECTIVE AT
4:01 P.M., EASTERN TIME, ON NOVEMBER 20, 2023
* VTV THERAPEUTICS-REVERSE STOCK SPLIT TO REGAIN COMPLIANCE
WITH
$1/SHARE MINIMUM CLOSING PRICE REQUIRED TO MAINTAIN CONTINUED
LISTING ON NASDAQ
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)